At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,499 enrolled
Drug / intervention
CRT Therapy - LV Lead Registrydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CELESTIAL Post Approval Registry: Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar Post Approval Registry
In Brief
An observational study evaluating CRT Therapy - LV Lead Registry for Congestive Heart Failure. Completed, enrolled 2,499 participants across 86 sites.
Detailed Summary
The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCongestive Heart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedDec 2008
Primary CompletionNov 2018
TodayJul 2026
First PostedDec 18, 2008
Enrollment StartDec 1, 2008
Primary CompletionNov 2, 2018
TodayJul 2, 2026
Enrollment to primary: 9.9 yearsPosted 17.5 years ago
Interventions
CRT Therapy - LV Lead Registrydevice
Collecting long-term safety and efficacy data on a market-released left ventricular lead.